CLINICAL SUPPLY REGULATORY ARTICLES

Bored worker throwing paper airplane-GettyImages-512753786 Warning To U.S.-Based CDMOs: Don't Get Complacent

How could I not ask him for an opinion regarding our vigorously pursued editorials on the WuXi Apptec–BIOSECURE Act. After all, Reza Oliyai has outsourced a myriad of development and manufacturing services to hundreds of CDMOs around the world. He did so at Gilead for decades, and since as the CEO  of his eponymous consulting company. His response did not disappoint.

CLINICAL SUPPLY REGULATORY VIDEOS

Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.

Decentralized clinical trials are made up of a multitude of elements, from in home clinical capabilities, logistics, digital platforms, and technology, to global reach and more. This webinar shares important factors to consider to build your DCT ‘molecule’ successfully.

Understand how free trade zones work, and explore a flexible and cost efficient way to supply clinical trials in China and around the globe.

In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

CLINICAL SUPPLY REGULATORY RESOURCES